In conclusion, we found that low BMP6/OLFM1 gene status is a potential biomarker to identify patients with high-risk pStage I pure solid nonsquamous NSCLC after pulmonary resection. This evidence concerns the gene OLFM1 and non-small cell lung carcinoma.